OpenOnward

11/29/2017

Find and donate to over 250 non-profit foundations supporting biomedical research

11/19/2017

"U.S. Food and Drug Administration is concerned that some patients seeking cures and remedies are vulnerable to stem cell treatments that are illegal and potentially harmful. And the FDA is increasing its oversight and enforcement to protect people from dishonest and unscrupulous stem cell clinics, while continuing to encourage innovation so that the medical industry can properly harness the potential of stem cell products."

Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem cell treatments that are illegal and potentially harmful. Here's what to know before you consider s...

11/17/2017

Regenerative medicine gets a boost from new FDA guidance for drug development

FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.

11/15/2017

Historic event in medicine today: First patient dosed with genome-editing therapy.

Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II Download as PDF November 15, 2017 RICHMOND, Calif., Nov. 15, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced treatment of the first patient in...

11/10/2017

American Cancer Society - 2017 Cancer Facts and Figures: About 1.7 million new cancer cases and over 600,000 deaths expected this year.

11/02/2017

CAR-T therapies are doing well (Novartis, Gilead/Kite, and Juno).

Juno Therapeutics announced new cancer trial results that could help the drugmaker leapfrog key competitors in the rapidly emerging cancer immunotherapy industry.

11/01/2017

Swiss drugmaker Novartis is seeking U.S. regulators' blessing for its Kymriah cell therapy to be used against a second form of blood cancer after winning initial approval for the treatment earlier this year.

10/05/2017

N Engl J Med. 2017 Oct 4. doi: 10.1056/NEJMoa1708120. [Epub ahead of print]

10/05/2017

PLYMOUTH MEETING, Pa., Oct. 05, 2017-- Inovio Pharmaceuticals, Inc. reported today on positive safety and immune response results from a first-in-man, multi-center phase 1 trial of a vaccine against the ...

10/04/2017

Cancer immunotherapy (Immuno-oncology or Immunooncology) is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the fact that cancer cells often have molecules on their surface that can be detect...

10/04/2017

Original Article from The New England Journal of Medicine — Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

10/02/2017

Circadian rhythm wins Nobel Prize in Medicine

Jeffrey C. Hall, Michael Rosbash and Michael W. Young were recognized for research into the cellular mechanisms controlling the body’s 24-hour cycle.